Floatz logo

Therapeutic Asset Ratings

159 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cediranib
Adenocarcinoma of the Pancreas
University Health Network, TorontoP3BB (70)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Headache
University Health Network, TorontoP4BB (69)
CIS-DIAMMINEDICHLOROPLATINUM II
BRCA1 Mutation Carrier
University Health Network, TorontoP2/3BB (68)
Capecitabine
Stage IV Breast Cancer
University Health Network, TorontoP3BB (66)
Eloxatin
Stage IV Breast Cancer
University Health Network, TorontoP3BB (66)
Relatlimab
Cutaneous Melanoma
University Health Network, TorontoP3BB (66)
Inno-206
Duct Cell Adenocarcinoma of the Pancreas
University Health Network, TorontoP2BB (66)
Indocyanine Green
Ulcer, Gastric
University Health Network, TorontoP4BB (65)
Semaglutide
Liver Transplant; Complications
University Health Network, TorontoP4BB (65)
Sitagliptin
Liver Transplant; Complications
University Health Network, TorontoP4BB (65)
Sitagliptin
Non-alcoholic Fatty Liver Disease
University Health Network, TorontoP4BB (64)
LIDOCAINE
Post-mastectomy Pain Syndrome
University Health Network, TorontoP3BB (64)
Rivaroxaban
Sickle Cell Anemia
University Health Network, TorontoP3BB (64)
Enasidenib
IDH2 Gene Mutation
University Health Network, TorontoP2BB (64)
CIS-DIAMMINEDICHLOROPLATINUM II
BRCA1/2 Mutation
University Health Network, TorontoP2/3BB (64)
Brigatinib
Advanced Malignancies
University Health Network, TorontoP3B (63)
TAMOXIFEN
Prostate Cancer
University Health Network, TorontoP3B (63)
Selinexor
Duct Cell Adenocarcinoma of the Pancreas
University Health Network, TorontoP2B (63)
Cediranib
Colorectal Cancer
University Health Network, TorontoP4B (62)
Indocyanine Green
Obesity, Morbid
University Health Network, TorontoP4B (62)
Vinorelbine
Cancer
University Health Network, TorontoP3B (62)
TAMOXIFEN
Hypogonadism
University Health Network, TorontoP2B (62)
Atezolizumab
Ovarian Endometrioid Tumor
University Health Network, TorontoP2/3B (62)
Tocilizumab
Refractory Cancer
University Health Network, TorontoP4B (61)
Cediranib
Adult Leiomyosarcoma
University Health Network, TorontoP2B (61)
Showing 1 to 25 of 159 assets
PreviousPage 1 of 7Next